CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
The new online Learning Center with new content can still be found under the “Training” folder on ...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization